On May 22, 2004, Modern Prometheus announced its Initial Public Offering of Common Stock, giving the public the opportunity to invest in the future of life on earth.  Biotechnology is the fastest growing business in the world so you can count on your investment growing as robustly as one of our carefully designed creations.   The contributions of Modern Prometheus hold the promise of solving age-old problems such as disease, aging, marital strife, low self-esteem, overpopulation, rebellious children and war, so your investment is not only for yourself but for generations to come.

Modern Prometheus LLC shares are listed on the Nasdac National Market under the symbol "MPLLC." All 2,150,000 shares are being sold by the company. The offering is managed by Mirrell Linch & Co., World Financial Square, 250 Vasey Street, New York, NY 10281; B.J. Morgen & Co., 6 Wall Street, New York, NY 10260; Dane Raucher Vessels, 60 South East Sixth Street, Minneapolis, MN 55402; Morgan Keenan & Company, Inc., 50 Beale Street, Memphis, TN 38103; and ViewSound Technology Grope, 22 Gatehorse Road, Stanford, CT 06902. MPLLC and certain selling stockholders have granted the underwriters an option to purchase up to 555,000 additional shares for the purpose of covering over-allotments, if any.